
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

The human stomach serves as more than just a digestive vessel; it is a sophisticated sensory organ. Central to this sensing capability is gastric nuclear receptor signaling, which interprets signals from ingested food and toxins. Nuclear receptors (NRs) are evolutionarily conserved proteins that act as transcription factors. These molecules regulate gene expression in response to environmental and hormonal stimuli. Therefore, understanding these pathways offers a bridge between external dietary factors and internal physiological balance.
Notably, the stomach hosts numerous NRs that dictate cell fate determination and normal development. These receptors respond to xenobiotics and pollutants, which is crucial since the stomach is a primary entry point for contaminants. Furthermore, signals from other organs engage gastric NRs to modulate physiology. Consequently, these interactions determine the activity of stem cells and acid-secreting parietal cells. Thus, NR signaling acts as a critical regulator of gastric architecture and functional integrity.
Moreover, disruptions in these signaling pathways contribute significantly to pathological states. Research demonstrates that NRs influence the development of precancerous lesions and gastric cancer. In addition, these receptors provide novel opportunities for pharmacological intervention. Identifying specific agonists and antagonists can help treat chronic conditions like gastritis and intestinal metaplasia. Therefore, targeting nuclear receptors represents a promising frontier in gastrointestinal oncology and metabolic medicine.
Nuclear receptors act as transcription factors that regulate gene expression. They manage cell differentiation, maintain homeostasis, and sense dietary toxins to protect the gastric lining.
The stomach is one of the first organs to encounter dietary compounds and environmental pollutants. These substances trigger specific nuclear receptors, which then adjust the activity of gastric stem cells and acid secretion.
Yes, researchers are investigating NRs as therapeutic targets. By using specific agonists or antagonists, clinicians may be able to modulate the pathological pathways involved in gastritis and gastric malignancy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult with a qualified healthcare provider regarding medical conditions or treatments. Refer to the latest local and national guidelines for clinical practice.
References
Divenko M et al. Stomach at the Crossroads: Nuclear Receptor Signaling at the Interface Between What We Are and What We Eat. Physiol Rev. 2026 Feb 24. doi: 10.1152/physrev.00033.2025. PMID: 41732976.
Tanaka T, De Luca LM. Therapeutic potential of nuclear receptors in the digestive tract. Journal of Gastroenterology. 2017;52(4):423-435. doi: 10.1007/s00535-017-1311-2.
Wang Z, et al. Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer. Oncotarget. 2017;8(10):16311-16321. doi: 10.18632/oncotarget.13958.

A detailed look at the role of nuclear receptors in gastric homeostasis, environmental response, and as therapeutic targets for gastritis and gastric cancer...
3 months ago

Study findings from a Mexican tertiary center reveal pernicious anemia as the leading cause of B12 deficiency, even in cases without macrocytosis....
Today

Research shows that FABP5 suppresses the PPARγ/CPT1A pathway, boosting energy and lowering ROS to resist chemotherapy in cervical cancer cells....
Today

A comprehensive review of the pathophysiology and multi-parametric diagnostic strategies for managing congestion in heart failure patients....
Today

An in-depth analysis of gene expression in embryonic chick skulls, focusing on matrix components like VCAN and IBSP in bone and cartilage development....
Today

New research suggests Fibroblast growth factor 21 (FGF21) could be a therapeutic candidate for psoriasis by regulating NF-κB and autophagy signaling pathway...
Today